WO2019024548A1 - 一种脂溶性营养素微胶囊及其制备方法 - Google Patents
一种脂溶性营养素微胶囊及其制备方法 Download PDFInfo
- Publication number
- WO2019024548A1 WO2019024548A1 PCT/CN2018/084596 CN2018084596W WO2019024548A1 WO 2019024548 A1 WO2019024548 A1 WO 2019024548A1 CN 2018084596 W CN2018084596 W CN 2018084596W WO 2019024548 A1 WO2019024548 A1 WO 2019024548A1
- Authority
- WO
- WIPO (PCT)
- Prior art keywords
- fat
- soluble
- soluble nutrient
- vitamin
- microcapsule
- Prior art date
Links
- 235000015097 nutrients Nutrition 0.000 title claims abstract description 84
- 239000003094 microcapsule Substances 0.000 title claims abstract description 59
- 238000002360 preparation method Methods 0.000 title abstract description 27
- 239000003995 emulsifying agent Substances 0.000 claims abstract description 30
- 239000000463 material Substances 0.000 claims abstract description 16
- 239000003963 antioxidant agent Substances 0.000 claims abstract description 12
- 239000006185 dispersion Substances 0.000 claims description 27
- 235000012680 lutein Nutrition 0.000 claims description 22
- 239000001656 lutein Substances 0.000 claims description 22
- 229960005375 lutein Drugs 0.000 claims description 22
- KBPHJBAIARWVSC-RGZFRNHPSA-N lutein Chemical compound C([C@H](O)CC=1C)C(C)(C)C=1\C=C\C(\C)=C\C=C\C(\C)=C\C=C\C=C(/C)\C=C\C=C(/C)\C=C\[C@H]1C(C)=C[C@H](O)CC1(C)C KBPHJBAIARWVSC-RGZFRNHPSA-N 0.000 claims description 22
- ORAKUVXRZWMARG-WZLJTJAWSA-N lutein Natural products CC(=C/C=C/C=C(C)/C=C/C=C(C)/C=C/C1=C(C)CCCC1(C)C)C=CC=C(/C)C=CC2C(=CC(O)CC2(C)C)C ORAKUVXRZWMARG-WZLJTJAWSA-N 0.000 claims description 22
- KBPHJBAIARWVSC-XQIHNALSSA-N trans-lutein Natural products CC(=C/C=C/C=C(C)/C=C/C=C(C)/C=C/C1=C(C)CC(O)CC1(C)C)C=CC=C(/C)C=CC2C(=CC(O)CC2(C)C)C KBPHJBAIARWVSC-XQIHNALSSA-N 0.000 claims description 22
- FJHBOVDFOQMZRV-XQIHNALSSA-N xanthophyll Natural products CC(=C/C=C/C=C(C)/C=C/C=C(C)/C=C/C1=C(C)CC(O)CC1(C)C)C=CC=C(/C)C=CC2C=C(C)C(O)CC2(C)C FJHBOVDFOQMZRV-XQIHNALSSA-N 0.000 claims description 22
- QYSXJUFSXHHAJI-XFEUOLMDSA-N Vitamin D3 Natural products C1(/[C@@H]2CC[C@@H]([C@]2(CCC1)C)[C@H](C)CCCC(C)C)=C/C=C1\C[C@@H](O)CCC1=C QYSXJUFSXHHAJI-XFEUOLMDSA-N 0.000 claims description 21
- 238000000034 method Methods 0.000 claims description 18
- 239000000839 emulsion Substances 0.000 claims description 16
- 229960000342 retinol acetate Drugs 0.000 claims description 15
- 235000019173 retinyl acetate Nutrition 0.000 claims description 15
- QGNJRVVDBSJHIZ-QHLGVNSISA-N retinyl acetate Chemical group CC(=O)OC\C=C(/C)\C=C\C=C(/C)\C=C\C1=C(C)CCCC1(C)C QGNJRVVDBSJHIZ-QHLGVNSISA-N 0.000 claims description 15
- 239000011770 retinyl acetate Substances 0.000 claims description 15
- 239000012071 phase Substances 0.000 claims description 13
- CIWBSHSKHKDKBQ-JLAZNSOCSA-N Ascorbic acid Chemical compound OC[C@H](O)[C@H]1OC(=O)C(O)=C1O CIWBSHSKHKDKBQ-JLAZNSOCSA-N 0.000 claims description 12
- 235000006708 antioxidants Nutrition 0.000 claims description 11
- 230000003078 antioxidant effect Effects 0.000 claims description 9
- 229920001353 Dextrin Polymers 0.000 claims description 8
- 239000004375 Dextrin Substances 0.000 claims description 8
- ACTIUHUUMQJHFO-UPTCCGCDSA-N coenzyme Q10 Chemical compound COC1=C(OC)C(=O)C(C\C=C(/C)CC\C=C(/C)CC\C=C(/C)CC\C=C(/C)CC\C=C(/C)CC\C=C(/C)CC\C=C(/C)CC\C=C(/C)CC\C=C(/C)CCC=C(C)C)=C(C)C1=O ACTIUHUUMQJHFO-UPTCCGCDSA-N 0.000 claims description 8
- 235000019425 dextrin Nutrition 0.000 claims description 8
- 239000007921 spray Substances 0.000 claims description 8
- 239000000084 colloidal system Substances 0.000 claims description 7
- GVJHHUAWPYXKBD-UHFFFAOYSA-N (±)-α-Tocopherol Chemical compound OC1=C(C)C(C)=C2OC(CCCC(C)CCCC(C)CCCC(C)C)(C)CCC2=C1C GVJHHUAWPYXKBD-UHFFFAOYSA-N 0.000 claims description 6
- 108010010803 Gelatin Proteins 0.000 claims description 6
- 230000008602 contraction Effects 0.000 claims description 6
- 229920000159 gelatin Polymers 0.000 claims description 6
- 239000008273 gelatin Substances 0.000 claims description 6
- 235000019322 gelatine Nutrition 0.000 claims description 6
- 235000011852 gelatine desserts Nutrition 0.000 claims description 6
- GVJHHUAWPYXKBD-IEOSBIPESA-N α-tocopherol Chemical compound OC1=C(C)C(C)=C2O[C@@](CCC[C@H](C)CCC[C@H](C)CCCC(C)C)(C)CCC2=C1C GVJHHUAWPYXKBD-IEOSBIPESA-N 0.000 claims description 6
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 claims description 5
- 239000008346 aqueous phase Substances 0.000 claims description 5
- 235000021466 carotenoid Nutrition 0.000 claims description 5
- 150000001747 carotenoids Chemical class 0.000 claims description 5
- 239000008103 glucose Substances 0.000 claims description 5
- 239000000203 mixture Substances 0.000 claims description 5
- 229940088594 vitamin Drugs 0.000 claims description 5
- 229930003231 vitamin Natural products 0.000 claims description 5
- 235000013343 vitamin Nutrition 0.000 claims description 5
- 239000011782 vitamin Substances 0.000 claims description 5
- 229920002261 Corn starch Polymers 0.000 claims description 4
- 229920000881 Modified starch Polymers 0.000 claims description 4
- 239000004368 Modified starch Substances 0.000 claims description 4
- ZTHYODDOHIVTJV-UHFFFAOYSA-N Propyl gallate Chemical group CCCOC(=O)C1=CC(O)=C(O)C(O)=C1 ZTHYODDOHIVTJV-UHFFFAOYSA-N 0.000 claims description 4
- VYGQUTWHTHXGQB-FFHKNEKCSA-N Retinol Palmitate Chemical compound CCCCCCCCCCCCCCCC(=O)OC\C=C(/C)\C=C\C=C(/C)\C=C\C1=C(C)CCCC1(C)C VYGQUTWHTHXGQB-FFHKNEKCSA-N 0.000 claims description 4
- 244000269722 Thea sinensis Species 0.000 claims description 4
- 235000010323 ascorbic acid Nutrition 0.000 claims description 4
- 239000011668 ascorbic acid Substances 0.000 claims description 4
- 229960005070 ascorbic acid Drugs 0.000 claims description 4
- FDSDTBUPSURDBL-LOFNIBRQSA-N canthaxanthin Chemical compound CC=1C(=O)CCC(C)(C)C=1/C=C/C(/C)=C/C=C/C(/C)=C/C=C/C=C(C)C=CC=C(C)C=CC1=C(C)C(=O)CCC1(C)C FDSDTBUPSURDBL-LOFNIBRQSA-N 0.000 claims description 4
- 150000001720 carbohydrates Chemical class 0.000 claims description 4
- 235000014633 carbohydrates Nutrition 0.000 claims description 4
- 239000011162 core material Substances 0.000 claims description 4
- 239000008120 corn starch Substances 0.000 claims description 4
- 235000019426 modified starch Nutrition 0.000 claims description 4
- 235000013824 polyphenols Nutrition 0.000 claims description 4
- 235000010378 sodium ascorbate Nutrition 0.000 claims description 4
- PPASLZSBLFJQEF-RKJRWTFHSA-M sodium ascorbate Substances [Na+].OC[C@@H](O)[C@H]1OC(=O)C(O)=C1[O-] PPASLZSBLFJQEF-RKJRWTFHSA-M 0.000 claims description 4
- 229960005055 sodium ascorbate Drugs 0.000 claims description 4
- PPASLZSBLFJQEF-RXSVEWSESA-M sodium-L-ascorbate Chemical compound [Na+].OC[C@H](O)[C@H]1OC(=O)C(O)=C1[O-] PPASLZSBLFJQEF-RXSVEWSESA-M 0.000 claims description 4
- 229930091371 Fructose Natural products 0.000 claims description 3
- RFSUNEUAIZKAJO-ARQDHWQXSA-N Fructose Chemical compound OC[C@H]1O[C@](O)(CO)[C@@H](O)[C@@H]1O RFSUNEUAIZKAJO-ARQDHWQXSA-N 0.000 claims description 3
- 239000005715 Fructose Substances 0.000 claims description 3
- 150000003722 vitamin derivatives Chemical class 0.000 claims description 3
- OWEGMIWEEQEYGQ-UHFFFAOYSA-N 100676-05-9 Natural products OC1C(O)C(O)C(CO)OC1OCC1C(O)C(O)C(O)C(OC2C(OC(O)C(O)C2O)CO)O1 OWEGMIWEEQEYGQ-UHFFFAOYSA-N 0.000 claims description 2
- GUOCOOQWZHQBJI-UHFFFAOYSA-N 4-oct-7-enoxy-4-oxobutanoic acid Chemical compound OC(=O)CCC(=O)OCCCCCCC=C GUOCOOQWZHQBJI-UHFFFAOYSA-N 0.000 claims description 2
- 244000215068 Acacia senegal Species 0.000 claims description 2
- JEBFVOLFMLUKLF-IFPLVEIFSA-N Astaxanthin Natural products CC(=C/C=C/C(=C/C=C/C1=C(C)C(=O)C(O)CC1(C)C)/C)C=CC=C(/C)C=CC=C(/C)C=CC2=C(C)C(=O)C(O)CC2(C)C JEBFVOLFMLUKLF-IFPLVEIFSA-N 0.000 claims description 2
- 229920000298 Cellophane Polymers 0.000 claims description 2
- ZAKOWWREFLAJOT-CEFNRUSXSA-N D-alpha-tocopherylacetate Chemical compound CC(=O)OC1=C(C)C(C)=C2O[C@@](CCC[C@H](C)CCC[C@H](C)CCCC(C)C)(C)CCC2=C1C ZAKOWWREFLAJOT-CEFNRUSXSA-N 0.000 claims description 2
- CIWBSHSKHKDKBQ-DUZGATOHSA-N D-araboascorbic acid Natural products OC[C@@H](O)[C@H]1OC(=O)C(O)=C1O CIWBSHSKHKDKBQ-DUZGATOHSA-N 0.000 claims description 2
- 229920000084 Gum arabic Polymers 0.000 claims description 2
- QAQJMLQRFWZOBN-LAUBAEHRSA-N L-ascorbyl-6-palmitate Chemical compound CCCCCCCCCCCCCCCC(=O)OC[C@H](O)[C@H]1OC(=O)C(O)=C1O QAQJMLQRFWZOBN-LAUBAEHRSA-N 0.000 claims description 2
- UPYKUZBSLRQECL-UKMVMLAPSA-N Lycopene Natural products CC(=C/C=C/C=C(C)/C=C/C=C(C)/C=C/C1C(=C)CCCC1(C)C)C=CC=C(/C)C=CC2C(=C)CCCC2(C)C UPYKUZBSLRQECL-UKMVMLAPSA-N 0.000 claims description 2
- JEVVKJMRZMXFBT-XWDZUXABSA-N Lycophyll Natural products OC/C(=C/CC/C(=C\C=C\C(=C/C=C/C(=C\C=C\C=C(/C=C/C=C(\C=C\C=C(/CC/C=C(/CO)\C)\C)/C)\C)/C)\C)/C)/C JEVVKJMRZMXFBT-XWDZUXABSA-N 0.000 claims description 2
- GUBGYTABKSRVRQ-PICCSMPSSA-N Maltose Natural products O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@@H]1O[C@@H]1[C@@H](CO)OC(O)[C@H](O)[C@H]1O GUBGYTABKSRVRQ-PICCSMPSSA-N 0.000 claims description 2
- OOUTWVMJGMVRQF-DOYZGLONSA-N Phoenicoxanthin Natural products CC(=C/C=C/C=C(C)/C=C/C=C(C)/C=C/C1=C(C)C(=O)C(O)CC1(C)C)C=CC=C(/C)C=CC2=C(C)C(=O)CCC2(C)C OOUTWVMJGMVRQF-DOYZGLONSA-N 0.000 claims description 2
- VYGQUTWHTHXGQB-UHFFFAOYSA-N Retinol hexadecanoate Natural products CCCCCCCCCCCCCCCC(=O)OCC=C(C)C=CC=C(C)C=CC1=C(C)CCCC1(C)C VYGQUTWHTHXGQB-UHFFFAOYSA-N 0.000 claims description 2
- 229920002472 Starch Polymers 0.000 claims description 2
- 229930003316 Vitamin D Natural products 0.000 claims description 2
- MECHNRXZTMCUDQ-UHFFFAOYSA-N Vitamin D2 Natural products C1CCC2(C)C(C(C)C=CC(C)C(C)C)CCC2C1=CC=C1CC(O)CCC1=C MECHNRXZTMCUDQ-UHFFFAOYSA-N 0.000 claims description 2
- 229930003427 Vitamin E Natural products 0.000 claims description 2
- 235000010489 acacia gum Nutrition 0.000 claims description 2
- 239000000205 acacia gum Substances 0.000 claims description 2
- OENHQHLEOONYIE-UKMVMLAPSA-N all-trans beta-carotene Natural products CC=1CCCC(C)(C)C=1/C=C/C(/C)=C/C=C/C(/C)=C/C=C/C=C(C)C=CC=C(C)C=CC1=C(C)CCCC1(C)C OENHQHLEOONYIE-UKMVMLAPSA-N 0.000 claims description 2
- 150000004347 all-trans-retinol derivatives Chemical class 0.000 claims description 2
- 229940087168 alpha tocopherol Drugs 0.000 claims description 2
- 235000013793 astaxanthin Nutrition 0.000 claims description 2
- 239000001168 astaxanthin Substances 0.000 claims description 2
- MQZIGYBFDRPAKN-ZWAPEEGVSA-N astaxanthin Chemical compound C([C@H](O)C(=O)C=1C)C(C)(C)C=1/C=C/C(/C)=C/C=C/C(/C)=C/C=C/C=C(C)C=CC=C(C)C=CC1=C(C)C(=O)[C@@H](O)CC1(C)C MQZIGYBFDRPAKN-ZWAPEEGVSA-N 0.000 claims description 2
- 229940022405 astaxanthin Drugs 0.000 claims description 2
- 235000013734 beta-carotene Nutrition 0.000 claims description 2
- 239000011648 beta-carotene Substances 0.000 claims description 2
- TUPZEYHYWIEDIH-WAIFQNFQSA-N beta-carotene Natural products CC(=C/C=C/C=C(C)/C=C/C=C(C)/C=C/C1=C(C)CCCC1(C)C)C=CC=C(/C)C=CC2=CCCCC2(C)C TUPZEYHYWIEDIH-WAIFQNFQSA-N 0.000 claims description 2
- GUBGYTABKSRVRQ-QUYVBRFLSA-N beta-maltose Chemical compound OC[C@H]1O[C@H](O[C@H]2[C@H](O)[C@@H](O)[C@H](O)O[C@@H]2CO)[C@H](O)[C@@H](O)[C@@H]1O GUBGYTABKSRVRQ-QUYVBRFLSA-N 0.000 claims description 2
- 229960002747 betacarotene Drugs 0.000 claims description 2
- 235000012682 canthaxanthin Nutrition 0.000 claims description 2
- 239000001659 canthaxanthin Substances 0.000 claims description 2
- 229940008033 canthaxanthin Drugs 0.000 claims description 2
- ZAKOWWREFLAJOT-UHFFFAOYSA-N d-alpha-Tocopheryl acetate Natural products CC(=O)OC1=C(C)C(C)=C2OC(CCCC(C)CCCC(C)CCCC(C)C)(C)CCC2=C1C ZAKOWWREFLAJOT-UHFFFAOYSA-N 0.000 claims description 2
- 229960002061 ergocalciferol Drugs 0.000 claims description 2
- 235000010350 erythorbic acid Nutrition 0.000 claims description 2
- 239000004318 erythorbic acid Substances 0.000 claims description 2
- WIGCFUFOHFEKBI-UHFFFAOYSA-N gamma-tocopherol Natural products CC(C)CCCC(C)CCCC(C)CCCC1CCC2C(C)C(O)C(C)C(C)C2O1 WIGCFUFOHFEKBI-UHFFFAOYSA-N 0.000 claims description 2
- 235000021552 granulated sugar Nutrition 0.000 claims description 2
- IPCSVZSSVZVIGE-UHFFFAOYSA-M hexadecanoate Chemical compound CCCCCCCCCCCCCCCC([O-])=O IPCSVZSSVZVIGE-UHFFFAOYSA-M 0.000 claims description 2
- 229940026239 isoascorbic acid Drugs 0.000 claims description 2
- AGBQKNBQESQNJD-UHFFFAOYSA-M lipoate Chemical compound [O-]C(=O)CCCCC1CCSS1 AGBQKNBQESQNJD-UHFFFAOYSA-M 0.000 claims description 2
- 235000019136 lipoic acid Nutrition 0.000 claims description 2
- 235000012661 lycopene Nutrition 0.000 claims description 2
- 239000001751 lycopene Substances 0.000 claims description 2
- OAIJSZIZWZSQBC-GYZMGTAESA-N lycopene Chemical compound CC(C)=CCC\C(C)=C\C=C\C(\C)=C\C=C\C(\C)=C\C=C\C=C(/C)\C=C\C=C(/C)\C=C\C=C(/C)CCC=C(C)C OAIJSZIZWZSQBC-GYZMGTAESA-N 0.000 claims description 2
- 229960004999 lycopene Drugs 0.000 claims description 2
- -1 polyphenol palmitate Chemical class 0.000 claims description 2
- 150000008442 polyphenolic compounds Chemical class 0.000 claims description 2
- 235000010388 propyl gallate Nutrition 0.000 claims description 2
- 239000000473 propyl gallate Substances 0.000 claims description 2
- 229940075579 propyl gallate Drugs 0.000 claims description 2
- 235000019172 retinyl palmitate Nutrition 0.000 claims description 2
- 229940108325 retinyl palmitate Drugs 0.000 claims description 2
- 239000011769 retinyl palmitate Substances 0.000 claims description 2
- 235000010352 sodium erythorbate Nutrition 0.000 claims description 2
- 239000004320 sodium erythorbate Substances 0.000 claims description 2
- RBWSWDPRDBEWCR-RKJRWTFHSA-N sodium;(2r)-2-[(2r)-3,4-dihydroxy-5-oxo-2h-furan-2-yl]-2-hydroxyethanolate Chemical compound [Na+].[O-]C[C@@H](O)[C@H]1OC(=O)C(O)=C1O RBWSWDPRDBEWCR-RKJRWTFHSA-N 0.000 claims description 2
- 235000019698 starch Nutrition 0.000 claims description 2
- 239000008107 starch Substances 0.000 claims description 2
- 229960002663 thioctic acid Drugs 0.000 claims description 2
- 229960000984 tocofersolan Drugs 0.000 claims description 2
- 229940042585 tocopherol acetate Drugs 0.000 claims description 2
- ZCIHMQAPACOQHT-ZGMPDRQDSA-N trans-isorenieratene Natural products CC(=C/C=C/C=C(C)/C=C/C=C(C)/C=C/c1c(C)ccc(C)c1C)C=CC=C(/C)C=Cc2c(C)ccc(C)c2C ZCIHMQAPACOQHT-ZGMPDRQDSA-N 0.000 claims description 2
- 235000019166 vitamin D Nutrition 0.000 claims description 2
- 239000011710 vitamin D Substances 0.000 claims description 2
- 150000003710 vitamin D derivatives Chemical class 0.000 claims description 2
- 235000001892 vitamin D2 Nutrition 0.000 claims description 2
- 239000011653 vitamin D2 Substances 0.000 claims description 2
- MECHNRXZTMCUDQ-RKHKHRCZSA-N vitamin D2 Chemical compound C1(/[C@@H]2CC[C@@H]([C@]2(CCC1)C)[C@H](C)/C=C/[C@H](C)C(C)C)=C\C=C1\C[C@@H](O)CCC1=C MECHNRXZTMCUDQ-RKHKHRCZSA-N 0.000 claims description 2
- 235000019165 vitamin E Nutrition 0.000 claims description 2
- 229940046009 vitamin E Drugs 0.000 claims description 2
- 239000011709 vitamin E Substances 0.000 claims description 2
- 150000003712 vitamin E derivatives Chemical class 0.000 claims description 2
- 229940046008 vitamin d Drugs 0.000 claims description 2
- 235000004835 α-tocopherol Nutrition 0.000 claims description 2
- 239000002076 α-tocopherol Substances 0.000 claims description 2
- OENHQHLEOONYIE-JLTXGRSLSA-N β-Carotene Chemical compound CC=1CCCC(C)(C)C=1\C=C\C(\C)=C\C=C\C(\C)=C\C=C\C=C(/C)\C=C\C=C(/C)\C=C\C1=C(C)CCCC1(C)C OENHQHLEOONYIE-JLTXGRSLSA-N 0.000 claims description 2
- GHKOFFNLGXMVNJ-UHFFFAOYSA-N Didodecyl thiobispropanoate Chemical compound CCCCCCCCCCCCOC(=O)CCSCCC(=O)OCCCCCCCCCCCC GHKOFFNLGXMVNJ-UHFFFAOYSA-N 0.000 claims 1
- 239000003508 Dilauryl thiodipropionate Substances 0.000 claims 1
- 235000019304 dilauryl thiodipropionate Nutrition 0.000 claims 1
- 239000013543 active substance Substances 0.000 abstract description 5
- 230000000694 effects Effects 0.000 abstract description 4
- 230000001804 emulsifying effect Effects 0.000 abstract description 3
- 238000004945 emulsification Methods 0.000 description 24
- QYSXJUFSXHHAJI-YRZJJWOYSA-N vitamin D3 Chemical compound C1(/[C@@H]2CC[C@@H]([C@]2(CCC1)C)[C@H](C)CCCC(C)C)=C\C=C1\C[C@@H](O)CCC1=C QYSXJUFSXHHAJI-YRZJJWOYSA-N 0.000 description 19
- 235000005282 vitamin D3 Nutrition 0.000 description 19
- 239000011647 vitamin D3 Substances 0.000 description 19
- 229940021056 vitamin d3 Drugs 0.000 description 19
- 230000014759 maintenance of location Effects 0.000 description 17
- 239000000843 powder Substances 0.000 description 12
- 239000000155 melt Substances 0.000 description 10
- 238000001694 spray drying Methods 0.000 description 10
- 238000001035 drying Methods 0.000 description 7
- 238000004519 manufacturing process Methods 0.000 description 7
- 239000003651 drinking water Substances 0.000 description 6
- 235000020188 drinking water Nutrition 0.000 description 6
- 238000005469 granulation Methods 0.000 description 6
- 230000003179 granulation Effects 0.000 description 6
- 230000008569 process Effects 0.000 description 6
- 238000010008 shearing Methods 0.000 description 6
- 238000013112 stability test Methods 0.000 description 6
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 6
- FPIPGXGPPPQFEQ-UHFFFAOYSA-N 13-cis retinol Natural products OCC=C(C)C=CC=C(C)C=CC1=C(C)CCCC1(C)C FPIPGXGPPPQFEQ-UHFFFAOYSA-N 0.000 description 5
- FPIPGXGPPPQFEQ-BOOMUCAASA-N Vitamin A Natural products OC/C=C(/C)\C=C\C=C(\C)/C=C/C1=C(C)CCCC1(C)C FPIPGXGPPPQFEQ-BOOMUCAASA-N 0.000 description 5
- FPIPGXGPPPQFEQ-OVSJKPMPSA-N all-trans-retinol Chemical compound OC\C=C(/C)\C=C\C=C(/C)\C=C\C1=C(C)CCCC1(C)C FPIPGXGPPPQFEQ-OVSJKPMPSA-N 0.000 description 5
- 239000012530 fluid Substances 0.000 description 5
- 235000019155 vitamin A Nutrition 0.000 description 5
- 239000011719 vitamin A Substances 0.000 description 5
- 229940045997 vitamin a Drugs 0.000 description 5
- IJGRMHOSHXDMSA-UHFFFAOYSA-N Atomic nitrogen Chemical compound N#N IJGRMHOSHXDMSA-UHFFFAOYSA-N 0.000 description 4
- 239000013078 crystal Substances 0.000 description 4
- 230000036541 health Effects 0.000 description 4
- 239000011859 microparticle Substances 0.000 description 4
- 239000003960 organic solvent Substances 0.000 description 4
- 239000004480 active ingredient Substances 0.000 description 3
- QVGXLLKOCUKJST-UHFFFAOYSA-N atomic oxygen Chemical compound [O] QVGXLLKOCUKJST-UHFFFAOYSA-N 0.000 description 3
- 235000017471 coenzyme Q10 Nutrition 0.000 description 3
- 230000000052 comparative effect Effects 0.000 description 3
- 235000013305 food Nutrition 0.000 description 3
- 238000002156 mixing Methods 0.000 description 3
- 239000001301 oxygen Substances 0.000 description 3
- 229910052760 oxygen Inorganic materials 0.000 description 3
- 230000001681 protective effect Effects 0.000 description 3
- ACTIUHUUMQJHFO-UHFFFAOYSA-N Coenzym Q10 Natural products COC1=C(OC)C(=O)C(CC=C(C)CCC=C(C)CCC=C(C)CCC=C(C)CCC=C(C)CCC=C(C)CCC=C(C)CCC=C(C)CCC=C(C)CCC=C(C)C)=C(C)C1=O ACTIUHUUMQJHFO-UHFFFAOYSA-N 0.000 description 2
- 241001465754 Metazoa Species 0.000 description 2
- 229930006000 Sucrose Natural products 0.000 description 2
- CZMRCDWAGMRECN-UGDNZRGBSA-N Sucrose Chemical compound O[C@H]1[C@H](O)[C@@H](CO)O[C@@]1(CO)O[C@@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O1 CZMRCDWAGMRECN-UGDNZRGBSA-N 0.000 description 2
- 230000003064 anti-oxidating effect Effects 0.000 description 2
- 239000011324 bead Substances 0.000 description 2
- 230000009286 beneficial effect Effects 0.000 description 2
- 210000004027 cell Anatomy 0.000 description 2
- 238000005265 energy consumption Methods 0.000 description 2
- 230000002708 enhancing effect Effects 0.000 description 2
- 150000002148 esters Chemical class 0.000 description 2
- 239000012467 final product Substances 0.000 description 2
- 239000002778 food additive Substances 0.000 description 2
- 238000000227 grinding Methods 0.000 description 2
- 238000000265 homogenisation Methods 0.000 description 2
- 229910052757 nitrogen Inorganic materials 0.000 description 2
- 230000035790 physiological processes and functions Effects 0.000 description 2
- 239000000047 product Substances 0.000 description 2
- 239000000126 substance Substances 0.000 description 2
- 235000010384 tocopherol Nutrition 0.000 description 2
- 229930003799 tocopherol Natural products 0.000 description 2
- 239000011732 tocopherol Substances 0.000 description 2
- 229960001295 tocopherol Drugs 0.000 description 2
- QTBSBXVTEAMEQO-UHFFFAOYSA-M Acetate Chemical compound CC([O-])=O QTBSBXVTEAMEQO-UHFFFAOYSA-M 0.000 description 1
- 208000024172 Cardiovascular disease Diseases 0.000 description 1
- ZZZCUOFIHGPKAK-UHFFFAOYSA-N D-erythro-ascorbic acid Natural products OCC1OC(=O)C(O)=C1O ZZZCUOFIHGPKAK-UHFFFAOYSA-N 0.000 description 1
- 102000004190 Enzymes Human genes 0.000 description 1
- 108090000790 Enzymes Proteins 0.000 description 1
- 241000282412 Homo Species 0.000 description 1
- DGAQECJNVWCQMB-PUAWFVPOSA-M Ilexoside XXIX Chemical compound C[C@@H]1CC[C@@]2(CC[C@@]3(C(=CC[C@H]4[C@]3(CC[C@@H]5[C@@]4(CC[C@@H](C5(C)C)OS(=O)(=O)[O-])C)C)[C@@H]2[C@]1(C)O)C)C(=O)O[C@H]6[C@@H]([C@H]([C@@H]([C@H](O6)CO)O)O)O.[Na+] DGAQECJNVWCQMB-PUAWFVPOSA-M 0.000 description 1
- 229930003268 Vitamin C Natural products 0.000 description 1
- 239000002253 acid Substances 0.000 description 1
- 230000009471 action Effects 0.000 description 1
- 239000011149 active material Substances 0.000 description 1
- 239000000654 additive Substances 0.000 description 1
- 230000000996 additive effect Effects 0.000 description 1
- 230000032683 aging Effects 0.000 description 1
- 239000003674 animal food additive Substances 0.000 description 1
- 230000008568 cell cell communication Effects 0.000 description 1
- 229940110767 coenzyme Q10 Drugs 0.000 description 1
- 238000004132 cross linking Methods 0.000 description 1
- 230000006866 deterioration Effects 0.000 description 1
- 230000002542 deteriorative effect Effects 0.000 description 1
- 230000018109 developmental process Effects 0.000 description 1
- 238000009826 distribution Methods 0.000 description 1
- 239000003814 drug Substances 0.000 description 1
- 238000005516 engineering process Methods 0.000 description 1
- 230000035558 fertility Effects 0.000 description 1
- 239000010419 fine particle Substances 0.000 description 1
- 238000005243 fluidization Methods 0.000 description 1
- 235000013373 food additive Nutrition 0.000 description 1
- 239000004519 grease Substances 0.000 description 1
- 230000012010 growth Effects 0.000 description 1
- 210000005260 human cell Anatomy 0.000 description 1
- 230000036737 immune function Effects 0.000 description 1
- 230000036039 immunity Effects 0.000 description 1
- 239000007788 liquid Substances 0.000 description 1
- 238000002844 melting Methods 0.000 description 1
- 230000008018 melting Effects 0.000 description 1
- 230000004060 metabolic process Effects 0.000 description 1
- 235000016709 nutrition Nutrition 0.000 description 1
- 230000035764 nutrition Effects 0.000 description 1
- 230000000704 physical effect Effects 0.000 description 1
- 239000000049 pigment Substances 0.000 description 1
- 108090000623 proteins and genes Proteins 0.000 description 1
- 102000004169 proteins and genes Human genes 0.000 description 1
- 230000001105 regulatory effect Effects 0.000 description 1
- 239000005871 repellent Substances 0.000 description 1
- 229910052708 sodium Inorganic materials 0.000 description 1
- 239000011734 sodium Substances 0.000 description 1
- XDLYMKFUPYZCMA-UHFFFAOYSA-M sodium;4-oct-1-enoxy-4-oxobutanoate Chemical compound [Na+].CCCCCCC=COC(=O)CCC([O-])=O XDLYMKFUPYZCMA-UHFFFAOYSA-M 0.000 description 1
- 239000007787 solid Substances 0.000 description 1
- 230000000087 stabilizing effect Effects 0.000 description 1
- 150000003431 steroids Chemical class 0.000 description 1
- 238000003756 stirring Methods 0.000 description 1
- 238000003860 storage Methods 0.000 description 1
- 239000000725 suspension Substances 0.000 description 1
- 235000019154 vitamin C Nutrition 0.000 description 1
- 239000011718 vitamin C Substances 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23K—FODDER
- A23K40/00—Shaping or working-up of animal feeding-stuffs
- A23K40/30—Shaping or working-up of animal feeding-stuffs by encapsulating; by coating
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23P—SHAPING OR WORKING OF FOODSTUFFS, NOT FULLY COVERED BY A SINGLE OTHER SUBCLASS
- A23P10/00—Shaping or working of foodstuffs characterised by the products
- A23P10/30—Encapsulation of particles, e.g. foodstuff additives
- A23P10/35—Encapsulation of particles, e.g. foodstuff additives with oils, lipids, monoglycerides or diglycerides
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23K—FODDER
- A23K20/00—Accessory food factors for animal feeding-stuffs
- A23K20/10—Organic substances
- A23K20/105—Aliphatic or alicyclic compounds
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23K—FODDER
- A23K20/00—Accessory food factors for animal feeding-stuffs
- A23K20/10—Organic substances
- A23K20/111—Aromatic compounds
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23K—FODDER
- A23K20/00—Accessory food factors for animal feeding-stuffs
- A23K20/10—Organic substances
- A23K20/174—Vitamins
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L29/00—Foods or foodstuffs containing additives; Preparation or treatment thereof
- A23L29/20—Foods or foodstuffs containing additives; Preparation or treatment thereof containing gelling or thickening agents
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
- A23L33/125—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives containing carbohydrate syrups; containing sugars; containing sugar alcohols; containing starch hydrolysates
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
- A23L33/15—Vitamins
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
- A23L33/15—Vitamins
- A23L33/155—Vitamins A or D
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23P—SHAPING OR WORKING OF FOODSTUFFS, NOT FULLY COVERED BY A SINGLE OTHER SUBCLASS
- A23P10/00—Shaping or working of foodstuffs characterised by the products
- A23P10/30—Encapsulation of particles, e.g. foodstuff additives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
- A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
- B01J—CHEMICAL OR PHYSICAL PROCESSES, e.g. CATALYSIS OR COLLOID CHEMISTRY; THEIR RELEVANT APPARATUS
- B01J13/00—Colloid chemistry, e.g. the production of colloidal materials or their solutions, not otherwise provided for; Making microcapsules or microballoons
- B01J13/02—Making microcapsules or microballoons
- B01J13/04—Making microcapsules or microballoons by physical processes, e.g. drying, spraying
- B01J13/043—Drying and spraying
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2002/00—Food compositions, function of food ingredients or processes for food or foodstuffs
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2250/00—Food ingredients
- A23V2250/30—Other Organic compounds
- A23V2250/314—Ubiquinone, coenzyme Qn
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2250/00—Food ingredients
- A23V2250/70—Vitamins
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
- B01J—CHEMICAL OR PHYSICAL PROCESSES, e.g. CATALYSIS OR COLLOID CHEMISTRY; THEIR RELEVANT APPARATUS
- B01J13/00—Colloid chemistry, e.g. the production of colloidal materials or their solutions, not otherwise provided for; Making microcapsules or microballoons
- B01J13/02—Making microcapsules or microballoons
- B01J13/04—Making microcapsules or microballoons by physical processes, e.g. drying, spraying
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
- B01J—CHEMICAL OR PHYSICAL PROCESSES, e.g. CATALYSIS OR COLLOID CHEMISTRY; THEIR RELEVANT APPARATUS
- B01J13/00—Colloid chemistry, e.g. the production of colloidal materials or their solutions, not otherwise provided for; Making microcapsules or microballoons
- B01J13/02—Making microcapsules or microballoons
- B01J13/06—Making microcapsules or microballoons by phase separation
Definitions
- the invention relates to the field of food and feed additives, in particular to a fat-soluble nutrient microcapsule and a preparation method thereof.
- the fat-soluble nutrient of the present invention mainly refers to a fat-soluble vitamin, a carotenoid and a coenzyme Q 10 .
- Vitamins are a kind of trace organic regulating substances that humans and animals must obtain from foods to maintain normal physiological functions. They play an important role in the growth, metabolism and development of the body; carotenoids are an important class of natural pigments. In general, it can improve the animal's fecundity, immune function, and has many physiological functions such as anti-oxidation, coloration and the ability to strengthen the communication between cells and cell seams.
- Coenzyme Q 10 is a fat-soluble steroid that activates human cells and The energy of cell energy has the functions of improving human immunity, enhancing anti-oxidation, delaying aging and enhancing vitality of the human body. It is widely used in cardiovascular diseases in medicine, and is widely used in nutrition and health care products and food additives at home and abroad.
- vitamins, carotenoids and coenzyme Q 10 are very unstable substances, they are extremely sensitive to light, heat and oxygen, and are not suitable for direct addition in feed or food. Therefore, many researchers and companies have developed their own As a method for stabilizing these active substances, such fat-soluble nutrients are usually prepared as microcapsules as an additive.
- the fat-soluble nutrient microcapsules are generally prepared by dissolving nutrients and other fat-soluble core materials in oil or organic solvents to form an oil phase, and then mixing with water containing water-soluble wall materials, using high-pressure homogenization and high-speed shearing. Emulsification by high-speed jet, ultrasonic cavitation, grinding, etc., followed by spray granulation and drying to obtain microcapsules.
- the patent CN101873848B improves the wall material of the microcapsule, which reports a preparation of a lipophilic health component comprising a lipophilic health component and a protective colloid, wherein the protective colloid is a modified starch having emulsifying ability,
- the lipophilic health component is selected from the group consisting of vitamin A, CoQ10, and esters thereof.
- Patent CN103549157B develops a microcapsule preparation method: adding a protein active enzyme to an emulsion containing nutrients, granulating, crosslinking, and drying to obtain a water-repellent vitamin microcapsule.
- Patent US8685446B2 provides a multi-walled microcapsule that is embedded with multiple protective colloids.
- the emulsion is easy to be layered in the process of waiting for spray drying after the completion of the emulsification, and the upper concentrated fat-soluble nutrient small oil beads are easily aggregated and become large oil beads, thereby affecting the package of the final product. Buried effect and bioavailability. Because of these influencing factors, the usual fat-soluble nutrient microcapsule products are partially lost in the preparation process, and the mass ratio of the active ingredient to the added fat-soluble nutrient in the final product is generally 90-96:100.
- the object of the present invention is to solve the problem that the fat-soluble nutrient microcapsules of the prior art lose some nutrients in the preparation process, and provide a fat-soluble nutrient microcapsule with high stability and high active substance content and a preparation method thereof.
- the present invention provides a fat-soluble nutrient microcapsule, which is in weight percentage, and the specific composition thereof is:
- the ratio of the fat-soluble nutrient which remains active in the fat-soluble nutrient microcapsule to the initially added fat-soluble nutrient is 0.990-0.997:1.
- the ratio of the fat-soluble nutrient which remains active in the microcapsules to the initially added fat-soluble nutrient is hereinafter referred to simply as the retention rate of the active substance, which indicates the loss of fat-soluble nutrients during the preparation.
- the invention also provides a preparation method of the fat-soluble nutrient microcapsule, which comprises mixing a molten fat-soluble nutrient oil phase or a pre-dispersion comprising a fat-soluble core material and an aqueous phase containing a water-soluble wall material or respectively feeding under high pressure
- the emulsion or dispersion obtained in the series cavitation emulsifier is subjected to spray granulation and drying to obtain a fat-soluble nutrient microcapsule.
- the fat-soluble nutrient microcapsule of the present invention directly uses a fat-soluble nutrient melt oil or a pre-dispersion as an oil phase, does not require the addition of an additional fat or an organic solvent, and the microcapsule-embedded effective fat-soluble nutrient is in the preparation process. The loss is small and the retention rate of the active substance is high.
- the method for preparing the fat-soluble nutrient microcapsule of the present invention adopts a continuous multi-stage series cavitation emulsification or dispersion method, which greatly reduces the emulsification or dispersion time, and effectively reduces the deterioration of the fat-soluble nutrient during the emulsification or dispersion process;
- the emulsion or dispersion prepared by the emulsification or dispersion method has good stability, and the obtained microcapsule has high embedding rate, and the surface of the microcapsule is substantially free of fat-soluble nutrient residues, and the prepared nutrient microcapsule has high stability.
- the preparation method of the fat-soluble nutrient microcapsule of the invention has low energy consumption and high efficiency.
- the fat-soluble nutrient microcapsule of the present invention requires only a small amount of an antioxidant to be added, and a high retention rate of the active material can be maintained without adding a fat-soluble antioxidant.
- the fat-soluble nutrient of the present invention is a vitamin A derivative, a vitamin E derivative, vitamin D, carotenoid, and coenzyme Q.
- the fat-soluble nutrient is an unstable nutrient, and specifically may be vitamin A acetate, vitamin A palmitate, vitamin E acetate, vitamin E palmitate, vitamin D2, vitamin D3, and beta-carotene.
- the antioxidants of the present invention are propyl gallate, BHT, tea polyphenol, alpha-tocopherol, L-ascorbic acid-6-palmitate, tea polyphenol palmitate, sodium ascorbate, ascorbic acid, thiodipropyl One or more of dilauryl acid ester and lipoic acid.
- the antioxidant is a water-soluble antioxidant, and may be one or more of ascorbic acid, sodium ascorbate, erythorbic acid, and sodium erythorbate.
- water-soluble antioxidants are beneficial to reduce the amount of oil phase in the process of emulsification or dispersion, increase the embedding rate of microcapsules, reduce the amount of oil phase exposed on the surface of microcapsules, and improve the stability of fat-soluble nutrients in spray granulation and drying stages.
- the wall material of the present invention is a water soluble colloid and a carbohydrate.
- the water-soluble colloid is one or more of gelatin, gum arabic, gelatinizable modified starch, and octenyl succinate starch.
- the carbohydrate is one or more of dextrin, glucose, white granulated sugar, fructose, maltose, cellophane, and corn starch.
- the present invention also provides a method for preparing the above-mentioned fat-soluble nutrient microcapsule, which comprises mixing a molten fat-soluble nutrient oil phase or a pre-dispersion comprising a fat-soluble core material and an aqueous phase containing a water-soluble wall material or respectively feeding under high pressure
- the emulsion or dispersion obtained in the series cavitation emulsifier is subjected to spray granulation and drying to obtain a fat-soluble nutrient microcapsule.
- the molten fat-soluble nutrient oil phase refers to a liquid oil phase of a fat-soluble nutrient obtained at a temperature higher than a melting point of a fat-soluble nutrient.
- the pre-dispersion of the fat-soluble nutrient refers to a nutrient solid suspension obtained by putting fat-soluble nutrients into water and uniformly dispersing them by grinding or the like.
- the multistage tandem cavitation emulsifier described above refers to an emulsifier in which a plurality of cavitation emulsifiers having abrupt shrinkage-expansion cross sections are used in series.
- the cavitation emulsifier is composed of a contraction section and an expansion section which are connected to each other. In each stage of the emulsifier, the fluid first passes through the contraction section and then enters the expansion section. In the cavitation emulsifier, the outlet of the constricted section and the outlet of the expanded section do not overlap all or part of the outlet direction of the constricted section.
- the decrease in the internal diameter of the constricted section is reduced (and not closed), and the fluid produces a high velocity in the constricted section that is significantly higher than the entrance of the constricted section and reaches a maximum at the junction of the constricted section and the expanded section.
- the fluid collides with the wall of the expansion section at a high speed, causing cavitation, thereby achieving an emulsification or dispersion effect.
- the multi-stage series cavitation emulsifier is a series cavitation emulsifier of 3 or more.
- the multistage tandem cavitation emulsifier is selected according to the physical properties of the fat-soluble nutrients, particularly the melt oil or the pre-dispersion of the fat-soluble nutrients and the viscosity of the water-soluble wall material solution.
- the multi-stage tandem cavitation emulsifier is a 5-10 stage series cavitation emulsifier.
- homogeneous emulsification or dispersion can be completed in a very short time by passing the fluid under high pressure at a high speed through a multistage series cavitation emulsifier.
- the high pressure is 100-500 MPa.
- the outlet velocity of the fluid in the contraction section of the cavitation emulsifier reaches a maximum value and impinges on the wall surface of the expansion section, thereby forming a plurality of cavitation emulsification or dispersion, which can be disposable in a short time.
- Complete emulsification or dispersion Complete emulsification or dispersion.
- the above oil phase is a molten fat-soluble nutrient or pre-dispersion, and no additional fat or organic solvent is added.
- the surface of the fat-soluble nutrient in contact with the external environment is small, and in combination with the above-mentioned emulsification or dispersion method, the prepared microcapsules have high active ingredients, and the active ingredients are almost no loss during the preparation.
- the above preparation method can be carried out under the protection of nitrogen.
- nitrogen protection can eliminate the effects of oxygen on the nutrients in the environment and ensure the stability of fat-soluble nutrients during the preparation of microcapsules.
- the water used in the above aqueous phase can be deoxidized in advance to further eliminate the influence of oxygen in the environment and improve the stability of the fat-soluble nutrients during the preparation of the microcapsules.
- the mass ratio of the hydrophilic wall material to the water is from 0.5 to 1:1.
- the above drying process may be spray drying, spray granulation-fluidization drying or the like.
- Vitamin A microcapsule and preparation thereof are Vitamin A microcapsule and preparation thereof
- the emulsion is continuously granulated into a spray granulation tower sprayed with corn starch, and then fluidized and dried to obtain vitamin A acetate fine particles.
- the content of each component is determined as shown in Table 1, and the production process is calculated.
- the vitamin A acetate retention rate was 99.7%.
- the vitamin A acetate microparticles were placed in a stability test at 25 ° C. After 6 months, the vitamin A acetate content in the microparticles was measured, and the retention rate of vitamin A acetate was calculated to be 98.2% after 6 months.
- Vitamin D3 microcapsule and preparation thereof are Vitamin D3 microcapsule and preparation thereof
- the content of each component was measured as shown in Table 1, and the retention rate of vitamin D3 in the production process was calculated to be 99.2%.
- the vitamin D3 dry powder was placed at 25 ° C for stability test. After 6 months, the vitamin D3 content in the vitamin D3 dry powder was measured. The retention rate of vitamin D3 was calculated to be 98.5% after 6 months.
- the lutein crystals 5.3Kg and water 30Kg were put into a ball mill and ground to 5 ⁇ m or less to obtain a pre-dispersion; 1050 L of drinking water was placed in the batching kettle, and then 190 kg of sodium octenyl succinate, 60 Kg of glucose, 250 Kg of dextrin, 5 Kg of VC sodium was stirred at a temperature to obtain a hydrosol solution; the predispersion and the hydrosol solution were uniformly mixed under stirring to obtain a dispersion.
- the above dispersion is pumped into a 6-stage series cavitation emulsifier by a high-pressure pump, the pressure of the apparatus is adjusted to 500 MPa, continuous dispersion is performed, a lutein dispersion is obtained at the outlet, and the lutein dispersion is continuously passed into the spray drying tower.
- the spray drying was carried out to obtain a dry powder of lutein, and the content of each component was measured as shown in Table 1.
- the lutein retention rate in the production process was calculated to be 99.6%.
- the lutein dry powder was placed at 25 ° C for stability test. After 6 months, the content of lutein in the dry powder of lutein was measured.
- the retention rate of lutein was calculated to be 99.2% after 6 months.
- Vitamin A microcapsule and preparation thereof are Vitamin A microcapsule and preparation thereof
- the content of each component is determined as shown in Table 1, and vitamin A in the production process is calculated.
- the acetate retention rate was 94.2%.
- the vitamin A was placed in a stability test at 25 ° C. After 6 months, the vitamin A acetate content in the vitamin A acetate microparticles was measured. The retention rate of vitamin A acetate was calculated to be 88.1% after 6 months. .
- Vitamin D3 microcapsule and preparation thereof are Vitamin D3 microcapsule and preparation thereof
- the content of each component was measured as shown in Table 1, and the vitamin D3 retention rate during the production process was calculated to be 96.5%.
- the above vitamin D3 dry powder was placed at 25 ° C for stability test, and after 6 months, the vitamin D3 content in the vitamin D3 dry powder was measured, and the retention rate of vitamin D3 was calculated to be 93.5% after 6 months.
- tocopherol into the melt kettle, and then add 5.3Kg of lutein crystals, heat up to 180 °C to melt all the materials, then cool to 90 °C to get melted oil; put 1050L of drinking water into the emulsifier, and then cast
- the gelled modified starch 190 Kg, fructose 60 Kg, and dextrin 250 Kg were stirred at a temperature to obtain a hydrosol solution.
- the above lutein melt oil was added dropwise to the emulsification kettle, and the emulsion was obtained by shearing at a high speed for 20 minutes.
- the lutein emulsion was sprayed into a spray drying tower for spray drying to obtain a dry powder of lutein.
- the content of each component was determined as shown in Table 1.
- the lutein retention rate during the production process was calculated to be 75.6%.
- the lutein dry powder was placed in a stability test at 25 ° C. After 6 months, the content of lutein in the dry powder of lutein was measured, and the retention rate of lutein was calculated to be 72.2% after 6 months.
- the group distribution ratio and the cavitation emulsifier series and pressure are according to Table 1, and the preparation process is different according to the second embodiment (Examples 4, 5, 10) or the third embodiment (Examples 6, 7, 8, and 9). Nutrient microcapsules were used to determine the content of each component, and the retention and stability of the nutrients were calculated. The results are shown in Table 1.
Landscapes
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Polymers & Plastics (AREA)
- Engineering & Computer Science (AREA)
- Food Science & Technology (AREA)
- Health & Medical Sciences (AREA)
- Zoology (AREA)
- Nutrition Science (AREA)
- Mycology (AREA)
- Animal Husbandry (AREA)
- Organic Chemistry (AREA)
- Dispersion Chemistry (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Molecular Biology (AREA)
- Veterinary Medicine (AREA)
- Medicinal Chemistry (AREA)
- Epidemiology (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Pharmacology & Pharmacy (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Biophysics (AREA)
- Medicinal Preparation (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Coloring Foods And Improving Nutritive Qualities (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- General Preparation And Processing Of Foods (AREA)
Abstract
Description
Claims (10)
- 根据权利要求1所述的脂溶性营养素微胶囊,其特征在于,所述的脂溶性营养素为维生素A衍生物、维生素E衍生物、维生素D、类胡萝卜素、辅酶Q 10中的一种或多种。
- 根据权利要求2所述的脂溶性营养素微胶囊,其特征在于,所述的脂溶性营养素为维生素A醋酸酯、维生素A棕榈酸脂、维生素E醋酸酯、维生素E棕榈酸脂、维生素D2、维生素D3、β-胡萝卜素、虾青素、番茄红素、斑蝥黄、叶黄素、辅酶Q 10中的一种或多种。
- 根据权利要求1所述的脂溶性营养素微胶囊,其特征在于,所述的抗氧化剂为没食子酸丙酯、BHT、茶多酚、α-生育酚、L-抗坏血酸-6-棕榈酸酯、茶多酚棕榈酸酯、抗坏血酸钠、抗坏血酸、硫代二丙酸二月桂酯、硫辛酸中的一种或多种;作为优选,所述的抗氧化剂为水溶性抗氧化剂,包含抗坏血酸、抗坏血酸钠、异抗坏血酸、异抗坏血酸钠中的一种或多种。
- 根据权利要求1所述的脂溶性营养素微胶囊,其特征在于,所述的壁材为水溶性胶体和碳水化合物。
- 根据权利要求5所述的脂溶性营养素微胶囊,其特征在于,所述的水溶性胶体为明胶、阿拉伯胶、可凝胶化的改性淀粉、辛烯基琥珀酸淀粉酯中的一种或多种;所述的碳水化合物为糊精、葡萄糖、白砂糖、果糖、麦芽糖、纤维糖、玉米淀粉中的一种或多种。
- 一种如权利要求1~6任一项所述的脂溶性营养素微胶囊的制备方 法,其特征在于,包括:将包含脂溶性芯材的熔融脂溶性营养素油相或预分散体和包含水溶性壁材的水相混合或者分别在高压下通入多级串联空化乳化器中进行乳化或分散,得到的乳化液或分散液进行喷雾造粒、干燥,即得到脂溶性营养素微胶囊。
- 根据权利要求7所述的脂溶性营养素微胶囊的制备方法,其特征在于,所述的多级串联空化乳化器为3级以上的串联空化乳化器;优选的,所述的多级串联空化乳化器为5-10级的串联空化乳化器。
- 根据权利要求7所述的脂溶性营养素微胶囊的制备方法,其特征在于,每一级空化乳化器由相互连通的收缩段和扩张段组成,收缩段的出口与扩张段的出口在收缩段的出口方向上不全部和不部分重叠。
- 根据权利要求7所述的脂溶性营养素微胶囊的制备方法,其特征在于,所述的高压压力为100-500Mpa。
Priority Applications (6)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
EP18841964.2A EP3607837B1 (en) | 2017-07-31 | 2018-04-26 | Fat-soluble nutrient microcapsule and preparation method therefor |
KR1020197028655A KR20190126830A (ko) | 2017-07-31 | 2018-04-26 | 지용성 영양소 마이크로캡슐 및 그의 제조 방법 |
JP2020502198A JP7205835B2 (ja) | 2017-07-31 | 2018-04-26 | 脂溶性栄養素マイクロカプセル及びその製造方法 |
CA3065840A CA3065840A1 (en) | 2017-07-31 | 2018-04-26 | Fat-soluble nutrient microcapsule and preparation method thereof |
US16/605,683 US20200029596A1 (en) | 2017-07-31 | 2018-04-26 | Fat-soluble nutrient microcapsule and preparation method thereof |
MX2019014381A MX2019014381A (es) | 2017-07-31 | 2018-04-26 | Microcapsula de nutriente liposoluble y metodo de preparacion de esta. |
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201710637373.3A CN107594597B (zh) | 2017-07-31 | 2017-07-31 | 一种脂溶性营养素微胶囊及其制备方法 |
CN201710637373.3 | 2017-07-31 |
Publications (1)
Publication Number | Publication Date |
---|---|
WO2019024548A1 true WO2019024548A1 (zh) | 2019-02-07 |
Family
ID=61064024
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PCT/CN2018/084596 WO2019024548A1 (zh) | 2017-07-31 | 2018-04-26 | 一种脂溶性营养素微胶囊及其制备方法 |
Country Status (8)
Country | Link |
---|---|
US (1) | US20200029596A1 (zh) |
EP (1) | EP3607837B1 (zh) |
JP (1) | JP7205835B2 (zh) |
KR (1) | KR20190126830A (zh) |
CN (1) | CN107594597B (zh) |
CA (1) | CA3065840A1 (zh) |
MX (1) | MX2019014381A (zh) |
WO (1) | WO2019024548A1 (zh) |
Families Citing this family (16)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN107594597B (zh) * | 2017-07-31 | 2020-05-12 | 浙江新和成股份有限公司 | 一种脂溶性营养素微胶囊及其制备方法 |
US20210000157A1 (en) * | 2018-03-15 | 2021-01-07 | Dsm Ip Assets B.V. | Extrudate comprising vitamin a |
CN109123660B (zh) * | 2018-09-17 | 2021-07-23 | 山西欧莱特农业科技有限公司 | 一种用于孕妇营养品的核桃乳清蛋白复合粉及其制备方法 |
CN109517080B (zh) * | 2018-11-06 | 2023-06-16 | 浙江大学 | 辛烯基琥珀酸淀粉酯、脂溶性营养素微胶囊及制备方法和应用 |
CN109452467B (zh) * | 2018-11-16 | 2022-03-18 | 厦门金达威维生素有限公司 | 一种维生素a微胶囊及其制备方法和应用 |
CN109452650A (zh) * | 2018-11-26 | 2019-03-12 | 荣海生物科技有限公司 | 一种新型亚麻籽油微胶囊及其制备方法 |
CN109674062A (zh) * | 2019-02-01 | 2019-04-26 | 浙江花园营养科技有限公司 | 一种稳定性维生素d3纳米冻干粉的制备方法 |
CN110693003A (zh) * | 2019-10-23 | 2020-01-17 | 华南理工大学 | 包埋脂溶性维生素的乳液凝胶及其基于脉冲电场的生产方法 |
CN110693848B (zh) * | 2019-10-26 | 2021-12-14 | 大连医诺生物股份有限公司 | 无抗氧化剂的维生素a微囊制剂及其制备方法 |
CN111202245A (zh) * | 2020-01-20 | 2020-05-29 | 瞿瀚鹏 | 维生素d2油脂微胶囊的制备方法、维生素d2油脂微胶囊及其应用 |
JP2023552161A (ja) * | 2020-11-25 | 2023-12-14 | シアトル フード テック,インコーポレイテッド | 自動肉類似品生産のための連続プロセス |
CN112515172A (zh) * | 2020-11-30 | 2021-03-19 | 厦门金达威生物科技有限公司 | 一种辅酶q10、vd3和vk2糖玻璃化微胶囊及其制备方法 |
CN116490080A (zh) * | 2020-11-30 | 2023-07-25 | 帝斯曼知识产权资产管理有限公司 | 抗氧化剂含量降低的新制剂及其制造和用途 |
CN115137018B (zh) * | 2021-03-30 | 2024-03-15 | 新发药业有限公司 | 一种维生素a及其衍生物组合物 |
CN113521027B (zh) * | 2021-06-07 | 2022-04-26 | 华中农业大学 | 一种富含虾青素的微胶囊制剂、其制备方法和应用 |
CN115886261A (zh) * | 2022-12-02 | 2023-04-04 | 南京泛成生物科技有限公司 | 鱼油微胶囊及其制备方法 |
Citations (14)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN106063534A (zh) | ||||
CN1044478A (zh) * | 1990-01-25 | 1990-08-08 | 轻工业部制盐工业科学研究所 | 水溶性胡萝卜素着色体的空化生产方法 |
CN1969833A (zh) * | 2005-11-25 | 2007-05-30 | 浙江医药股份有限公司新昌制药厂 | 含辅酶q10的干粉组合物及其制备方法 |
CN101744790A (zh) | 2010-01-22 | 2010-06-23 | 浙江大学 | 一种连续化稳定维生素a微胶囊的制备方法 |
CN101873848A (zh) | 2007-07-19 | 2010-10-27 | 帝斯曼知识产权资产管理有限公司 | 亲脂性健康成分的可片剂化制剂 |
CN101902922A (zh) | 2007-12-21 | 2010-12-01 | 巴斯夫欧洲公司 | 含有脂溶性活性物质的微胶囊 |
CN102026718A (zh) * | 2008-05-15 | 2011-04-20 | 希卡技术私人有限公司 | 设计用于过程强化的水力空化反应器的方法 |
US20110183033A1 (en) * | 2008-07-23 | 2011-07-28 | Gillot Sandra | Chia-based fatty acids food product, rich in omega-3, with good stability |
CN103404955A (zh) * | 2013-06-28 | 2013-11-27 | 大连医诺生物有限公司 | 一种多层包埋微粒的制备方法及装备 |
CN103549157A (zh) | 2013-11-14 | 2014-02-05 | 厦门金达威集团股份有限公司 | 斥水型维生素微胶囊的制备方法 |
US8685446B2 (en) | 2003-12-18 | 2014-04-01 | Victor Casana-Giner | Continuous multi-microencapsulation process for improving the stability and storage life of biologically active ingredients |
CN105663082A (zh) * | 2016-01-21 | 2016-06-15 | 江苏怀仁生物科技有限公司 | 一种强抗氧化性叶黄素微胶囊及其制备方法 |
WO2016169942A1 (en) | 2015-04-22 | 2016-10-27 | Basf Se | Nanoparticles, nanoemulsions and their formation with mixing chamber micronization |
CN107594597A (zh) * | 2017-07-31 | 2018-01-19 | 浙江新维普添加剂有限公司 | 一种脂溶性营养素微胶囊及其制备方法 |
Family Cites Families (13)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US2663688A (en) * | 1949-07-18 | 1953-12-22 | Walter A Patrick | Process of deoxidizing water |
CN2122945U (zh) * | 1992-03-10 | 1992-11-25 | 蒋运韬 | 随机燃油乳化装置 |
EP1377180B1 (en) * | 2001-04-10 | 2007-08-29 | Basf Aktiengesellschaft | Microcapsules |
US7803413B2 (en) * | 2005-10-31 | 2010-09-28 | General Mills Ip Holdings Ii, Llc. | Encapsulation of readily oxidizable components |
US8042989B2 (en) * | 2009-05-12 | 2011-10-25 | Cavitation Technologies, Inc. | Multi-stage cavitation device |
JP5339980B2 (ja) * | 2009-03-23 | 2013-11-13 | 富士フイルム株式会社 | 分散組成物及び分散組成物の製造方法 |
CN101549273B (zh) * | 2009-03-30 | 2011-06-15 | 浙江新和成股份有限公司 | 纳米分散的高全反式类胡萝卜素微胶囊的制备方法 |
CN101513394B (zh) * | 2009-03-30 | 2011-04-27 | 浙江新和成股份有限公司 | 连续化纳米分散维生素a微胶囊的制备方法 |
CN101703181A (zh) * | 2009-12-18 | 2010-05-12 | 周鑫 | 一种功能型大豆糖蛋白微胶囊 |
US9173818B2 (en) * | 2011-03-25 | 2015-11-03 | Zhejiang Nhu Company Ltd | Method for preparing stable-type vitamin A microcapsules continuously |
CN102224934B (zh) * | 2011-05-30 | 2013-09-18 | 何德海 | 一种用于饮料的维生素a微胶囊营养强化剂的制备方法 |
CN106666731B (zh) * | 2016-12-29 | 2020-05-12 | 浙江新和成股份有限公司 | 一种稳定的脂溶性营养素微胶囊及其制备方法和应用 |
CN106690277B (zh) * | 2016-12-29 | 2020-05-22 | 浙江新和成股份有限公司 | 一种固载化脂溶性营养素制剂及其制备方法和应用 |
-
2017
- 2017-07-31 CN CN201710637373.3A patent/CN107594597B/zh active Active
-
2018
- 2018-04-26 MX MX2019014381A patent/MX2019014381A/es unknown
- 2018-04-26 EP EP18841964.2A patent/EP3607837B1/en active Active
- 2018-04-26 WO PCT/CN2018/084596 patent/WO2019024548A1/zh unknown
- 2018-04-26 US US16/605,683 patent/US20200029596A1/en not_active Abandoned
- 2018-04-26 CA CA3065840A patent/CA3065840A1/en active Pending
- 2018-04-26 JP JP2020502198A patent/JP7205835B2/ja active Active
- 2018-04-26 KR KR1020197028655A patent/KR20190126830A/ko not_active IP Right Cessation
Patent Citations (14)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN106063534A (zh) | ||||
CN1044478A (zh) * | 1990-01-25 | 1990-08-08 | 轻工业部制盐工业科学研究所 | 水溶性胡萝卜素着色体的空化生产方法 |
US8685446B2 (en) | 2003-12-18 | 2014-04-01 | Victor Casana-Giner | Continuous multi-microencapsulation process for improving the stability and storage life of biologically active ingredients |
CN1969833A (zh) * | 2005-11-25 | 2007-05-30 | 浙江医药股份有限公司新昌制药厂 | 含辅酶q10的干粉组合物及其制备方法 |
CN101873848A (zh) | 2007-07-19 | 2010-10-27 | 帝斯曼知识产权资产管理有限公司 | 亲脂性健康成分的可片剂化制剂 |
CN101902922A (zh) | 2007-12-21 | 2010-12-01 | 巴斯夫欧洲公司 | 含有脂溶性活性物质的微胶囊 |
CN102026718A (zh) * | 2008-05-15 | 2011-04-20 | 希卡技术私人有限公司 | 设计用于过程强化的水力空化反应器的方法 |
US20110183033A1 (en) * | 2008-07-23 | 2011-07-28 | Gillot Sandra | Chia-based fatty acids food product, rich in omega-3, with good stability |
CN101744790A (zh) | 2010-01-22 | 2010-06-23 | 浙江大学 | 一种连续化稳定维生素a微胶囊的制备方法 |
CN103404955A (zh) * | 2013-06-28 | 2013-11-27 | 大连医诺生物有限公司 | 一种多层包埋微粒的制备方法及装备 |
CN103549157A (zh) | 2013-11-14 | 2014-02-05 | 厦门金达威集团股份有限公司 | 斥水型维生素微胶囊的制备方法 |
WO2016169942A1 (en) | 2015-04-22 | 2016-10-27 | Basf Se | Nanoparticles, nanoemulsions and their formation with mixing chamber micronization |
CN105663082A (zh) * | 2016-01-21 | 2016-06-15 | 江苏怀仁生物科技有限公司 | 一种强抗氧化性叶黄素微胶囊及其制备方法 |
CN107594597A (zh) * | 2017-07-31 | 2018-01-19 | 浙江新维普添加剂有限公司 | 一种脂溶性营养素微胶囊及其制备方法 |
Non-Patent Citations (3)
Title |
---|
"Cosmetics Science and Technology vol. 3 (non-official translation)", vol. 3, 31 March 2016, China, article "1.6.3.3 ; Pipeline dispersion/emulsifier", pages: 2272 - 2275, XP009517542 * |
REN, DIFENG: "1. 6. 3. 3 Inline Dispersing / Emulsifying Machine", MODERN FOOD PROCESSING TECHNOLOGY, 31 August 2015 (2015-08-31), pages 2272 - 2275, XP009517542, ISBN: 978-7-5184-0471-1 * |
See also references of EP3607837A4 |
Also Published As
Publication number | Publication date |
---|---|
JP2020528746A (ja) | 2020-10-01 |
CN107594597A (zh) | 2018-01-19 |
EP3607837B1 (en) | 2024-05-22 |
EP3607837C0 (en) | 2024-05-22 |
JP7205835B2 (ja) | 2023-01-17 |
US20200029596A1 (en) | 2020-01-30 |
CA3065840A1 (en) | 2019-02-07 |
MX2019014381A (es) | 2020-01-23 |
EP3607837A1 (en) | 2020-02-12 |
KR20190126830A (ko) | 2019-11-12 |
EP3607837A4 (en) | 2020-05-06 |
CN107594597B (zh) | 2020-05-12 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
WO2019024548A1 (zh) | 一种脂溶性营养素微胶囊及其制备方法 | |
AU2008340061B2 (en) | Microcapsules comprising a fat -soluble active substance | |
US6863914B1 (en) | Stable, aqueous dispersions and stable, water-dispersible dry powders of xanthophylls, and production and use of the same | |
US5364563A (en) | Powdered aqueous carotenoid dispersions | |
US11278856B2 (en) | Lutein microcapsule formulation and preparation method thereof | |
US3655406A (en) | Carotenoid compositions | |
US20230063291A1 (en) | Stable carotenoid microcapsule having high bioavailability and preparation method therefor | |
CN108148444B (zh) | 一种用于着色的高含量β-胡萝卜素微胶囊的制备方法 | |
JP3914619B2 (ja) | 脂溶性ビタミン混合物の安定なエマルジヨン及び乾燥粉末、その製造、その使用及びこれを含有する食料品、医薬品又は動物飼料 | |
CN105639647B (zh) | 一种维生素、类胡萝卜素粉剂及其制备方法和应用 | |
KR20200015884A (ko) | 안정한 지용성 활성 성분 조성물, 마이크로캡슐 및 이의 제조 방법과 용도 | |
CN107836716B (zh) | 一种藻油微胶囊及其制备方法和应用 | |
CN109418541B (zh) | 一种斥水型脂溶性维生素微胶囊的制备方法 | |
CN107897915A (zh) | 一种负载姜黄素的莲子蛋白‑果胶复合乳液及其制备方法和应用 | |
CN110693848B (zh) | 无抗氧化剂的维生素a微囊制剂及其制备方法 | |
US9173818B2 (en) | Method for preparing stable-type vitamin A microcapsules continuously | |
CN110547455A (zh) | 一种含有唾液酸与类胡萝卜素的微胶囊及其制备方法和应用 | |
CN102362864A (zh) | 提高维生素a或维生素d3微胶囊流散性和堆密度的方法 | |
CN111714466A (zh) | 一种高生物利用度高稳定性的类胡萝卜素制剂的制备方法 | |
CN113575945B (zh) | 一种纳米级高全反式类胡萝卜素干粉的制备方法 | |
CN113925157B (zh) | 一种β-胡萝卜素乳液及其制备方法 | |
CN112167615B (zh) | 一种疏水型脂溶性营养素微胶囊及其制备方法 | |
CN114668726A (zh) | 一种维生素d3混合粉及其制备方法 | |
CN115554264B (zh) | 一种维生素d3制剂、其制备方法和应用 | |
CN110547456A (zh) | 一种以唾液酸为包衣材料的类胡萝卜素微胶囊及其制备方法和应用 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
121 | Ep: the epo has been informed by wipo that ep was designated in this application |
Ref document number: 18841964 Country of ref document: EP Kind code of ref document: A1 |
|
ENP | Entry into the national phase |
Ref document number: 20197028655 Country of ref document: KR Kind code of ref document: A |
|
ENP | Entry into the national phase |
Ref document number: 2018841964 Country of ref document: EP Effective date: 20191107 |
|
ENP | Entry into the national phase |
Ref document number: 3065840 Country of ref document: CA |
|
ENP | Entry into the national phase |
Ref document number: 2020502198 Country of ref document: JP Kind code of ref document: A |
|
NENP | Non-entry into the national phase |
Ref country code: DE |